WhatFinger

They want booster approval based on studies covering about 300 people - with no control arms. BUT IT GETS BETTER. They tested it in 12 (yes, 12!) people over 65.

Are you kidding me, Pfizer, volume 1 gazillion


By News on the Net -- Alex Berenson——--September 17, 2021

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us


The FDA just released its briefing book for Pfizer’s request for a third dose of Comirnaty (or is that BNT162b2? No matter! It’s approved either way, sorta). It is every bit the mess we all expected. Let’s go to the highlights: Pfizer basically hasn’t bothered to test the booster AT ALL in the people actually at risk - it conducted a single “Phase 1” trial that covered 12 people over 65. The main Phase 2/3 booster trial (beware efforts to cover multiple “phases” of drug research at once, you want it bad you get it bad) included no one over 55.-- More...



Subscribe

View Comments

News on the Net——

News from around the world


Sponsored